S 868

Florida Senate - 2026  SB 868
By Senator Sharief
35-01084-26  2026868__
1A bill to be entitled
2An act relating to practice of the profession of
3pharmacy; amending s. 465.003, F.S.; revising the
4definition of the term “practice of the profession of
5pharmacy”; creating s. 465.1894, F.S.; authorizing
6pharmacists who meet specified criteria to, at the
7direction of a licensed physician, administer
8medications at a Level I or Level II trauma center
9under certain circumstances; requiring trauma centers
10to retain certain documentation to employ pharmacists
11to perform such tasks; requiring the Board of Pharmacy
12to adopt rules; reenacting ss. 465.1901 and
13626.8825(1)(r), F.S., relating to the practice of
14orthotics and pedorthics and pharmacy benefit manager
15transparency and accountability, respectively, to
16incorporate the amendment made by this act to s.
17465.003, F.S., in references thereto; providing an
18effective date.
19
20Be It Enacted by the Legislature of the State of Florida:
21
22Section 1. Subsection (22) of section 465.003, Florida
23Statutes, is amended to read:
24465.003 Definitions.—As used in this chapter, the term:
25(22) “Practice of the profession of pharmacy” includes
26compounding, dispensing, and consulting concerning contents,
27therapeutic values, and uses of any medicinal drug; consulting
28concerning therapeutic values and interactions of patent or
29proprietary preparations, whether pursuant to prescriptions or
30in the absence and entirely independent of such prescriptions or
31orders; and conducting other pharmaceutical services. For
32purposes of this subsection, the term “other pharmaceutical
33services” means monitoring the patient’s drug therapy and
34assisting the patient in the management of his or her drug
35therapy, and includes reviewing, and making recommendations
36regarding, the patient’s drug therapy and health care status in
37communication with the patient’s prescribing health care
38provider as licensed under chapter 458, chapter 459, chapter
39461, or chapter 466, or a similar statutory provision in another
40jurisdiction, or such provider’s agent or such other persons as
41specifically authorized by the patient; and initiating,
42modifying, or discontinuing drug therapy for a chronic health
43condition under a collaborative pharmacy practice agreement.
44This subsection may not be interpreted to permit an alteration
45of a prescriber’s directions, the diagnosis or treatment of any
46disease, the initiation of any drug therapy, the practice of
47medicine, or the practice of osteopathic medicine, unless
48otherwise permitted by law or specifically authorized by s.
49465.1865 or s. 465.1895. The term “practice of the profession of
50pharmacy” also includes any other act, service, operation,
51research, or transaction incidental to, or forming a part of,
52any of the foregoing acts, requiring, involving, or employing
53the science or art of any branch of the pharmaceutical
54profession, study, or training, and shall expressly permit a
55pharmacist to transmit information from persons authorized to
56prescribe medicinal drugs to their patients. The practice of the
57profession of pharmacy also includes the administration of
58vaccines to adults pursuant to s. 465.189; the testing or
59screening for and treatment of minor, nonchronic health
60conditions pursuant to s. 465.1895; and the preparation of
61prepackaged drug products in facilities holding Class III
62institutional pharmacy permits. The term also includes the
63ordering and evaluating of any laboratory or clinical testing;
64conducting patient assessments; and modifying, discontinuing, or
65administering medicinal drugs pursuant to s. 465.0125 by a
66consultant pharmacist. The term also includes the ordering and
67administration of the federal Clinical Laboratory Improvement
68Amendments-waived tests, including serology tests authorized by
69the United States Food and Drug Administration (FDA) or an
70equivalent regulatory authorization, subject to the disclaimers
71and limitations required by the FDA for such tests.
72Section 2. Section 465.1894, Florida Statutes, is created
73to read:
74465.1894Administration of medications.—
75(1)A pharmacist, at the direction of a physician licensed
76under chapter 458 or chapter 459, who meets the following
77qualifications may administer medications to a patient during a
78life-threatening emergency event at a Level I or Level II trauma
79center when delegated to perform such task:
80(a)The pharmacist has completed an accredited postgraduate
81residency training program; or
82(b)The pharmacist has completed at least 3 years of direct
83patient care in a hospital setting.
84
85Each trauma center must retain on record documentation of a
86pharmacist’s qualification under paragraph (a) or paragraph (b)
87to perform such tasks before employing the pharmacist to
88administer medication under this subsection.
89(2)The board shall adopt rules to administer this section.
90Section 3. For the purpose of incorporating the amendment
91made by this act to section 465.003, Florida Statutes, in a
92reference thereto, section 465.1901, Florida Statutes, is
93reenacted to read:
94465.1901 Practice of orthotics and pedorthics.—The
95provisions of chapter 468 relating to orthotics or pedorthics do
96not apply to any licensed pharmacist or to any person acting
97under the supervision of a licensed pharmacist. The practice of
98orthotics or pedorthics by a pharmacist or any of the
99pharmacist’s employees acting under the supervision of a
100pharmacist shall be construed to be within the meaning of the
101term “practice of the profession of pharmacy” as defined in s.
102465.003, and shall be subject to regulation in the same manner
103as any other pharmacy practice. The Board of Pharmacy shall
104develop rules regarding the practice of orthotics and pedorthics
105by a pharmacist. Any pharmacist or person under the supervision
106of a pharmacist engaged in the practice of orthotics or
107pedorthics is not precluded from continuing that practice
108pending adoption of these rules.
109Section 4. For the purpose of incorporating the amendment
110made by this act to section 465.003, Florida Statutes, in a
111reference thereto, paragraph (r) of subsection (1) of section
112626.8825, Florida Statutes, is reenacted to read:
113626.8825 Pharmacy benefit manager transparency and
114accountability.—
115(1) DEFINITIONS.—As used in this section, the term:
116(r) “Pharmacist services” means products, goods, and
117services or any combination of products, goods, and services
118provided as part of the practice of the profession of pharmacy
119as defined in s. 465.003 or otherwise covered by a pharmacy
120benefits plan or program.
121Section 5. This act shall take effect July 1, 2026.